Segall Bryant & Hamill’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $79M | Sell |
1,109,048
-109,297
| -9% | -$7.47M | 1.13% | 6 |
|
|
2025
Q4 | $72.1M | Sell |
1,218,345
-80,316
| -6% | -$4.36M | 0.98% | 7 |
|
|
2025
Q3 | $71.7M | Buy |
1,298,661
+15,451
| +1% | +$804K | 0.95% | 7 |
|
|
2025
Q2 | $55.3M | Buy |
1,283,210
+3,948
| +0.3% | +$152K | 0.78% | 12 |
|
|
2025
Q1 | $50.6M | Sell |
1,279,262
-8,019
| -0.6% | -$355K | 0.78% | 13 |
|
|
2024
Q4 | $52.5M | Buy |
1,287,281
+101,866
| +9% | +$4.24M | 0.72% | 18 |
|
|
2024
Q3 | $46.2M | Buy |
1,185,415
+297,135
| +33% | +$11.8M | 0.63% | 30 |
|
|
2024
Q2 | $38.8M | Sell |
888,280
-11,183
| -1% | -$540K | 0.69% | 27 |
|
|
2024
Q1 | $42.9M | Buy |
899,463
+833,843
| +1,271% | +$37.5M | 0.8% | 27 |
|
|
2023
Q4 | $3.1M | Buy |
65,620
+13,253
| +25% | +$550K | 0.06% | 276 |
|
|
2023
Q3 | $2.49M | Buy |
52,367
+7,371
| +16% | +$402K | 0.03% | 397 |
|
|
2023
Q2 | $2.62M | Sell |
44,996
-41
| -0.1% | -$2.46K | 0.03% | 405 |
|
|
2023
Q1 | $3.22M | Sell |
45,037
-246
| -0.5% | -$19.5K | 0.03% | 384 |
|
|
2022
Q4 | $3.19M | Buy |
45,283
+7,086
| +19% | +$500K | 0.04% | 379 |
|
|
2022
Q3 | $2.31M | Buy |
38,197
+3,091
| +9% | +$207K | 0.03% | 411 |
|
|
2022
Q2 | $2.22M | Buy |
35,106
+723
| +2% | +$47.1K | 0.03% | 413 |
|
|
2022
Q1 | $2.2M | Sell |
34,383
-73,756
| -68% | -$4.93M | 0.02% | 427 |
|
|
2021
Q4 | $7.75M | Buy |
108,139
+2,746
| +3% | +$209K | 0.07% | 236 |
|
|
2021
Q3 | $7.52M | Buy |
105,393
+550
| +0.5% | +$43.4K | 0.07% | 252 |
|
|
2021
Q2 | $8.53M | Sell |
104,843
-1,405
| -1% | -$113K | 0.08% | 234 |
|
|
2021
Q1 | $8.03M | Sell |
106,248
-15,792
| -13% | -$1.15M | 0.08% | 243 |
|
|
2020
Q4 | $9.24M | Sell |
122,040
-31,270
| -20% | -$2.04M | 0.1% | 205 |
|
|
2020
Q3 | $7.58M | Buy |
153,310
+56,532
| +58% | +$3.19M | 0.1% | 201 |
|
|
2020
Q2 | $5.09M | Sell |
96,778
-11,048
| -10% | -$524K | 0.09% | 214 |
|
|
2020
Q1 | $3.79M | Sell |
107,826
-373,865
| -78% | -$21.8M | 0.08% | 235 |
|
|
2019
Q4 | $42.1M | Sell |
481,691
-1,631
| -0.3% | -$143K | 0.65% | 43 |
|
|
2019
Q3 | $41M | Sell |
483,322
-7,933
| -2% | -$707K | 0.64% | 41 |
|
|
2019
Q2 | $51.7M | Buy |
491,255
+20,083
| +4% | +$2.02M | 0.78% | 28 |
|
|
2019
Q1 | $49.7M | Sell |
471,172
-11,833
| -2% | -$1.19M | 0.77% | 25 |
|
|
2018
Q4 | $40.4M | Buy |
483,005
+26,054
| +6% | +$2.36M | 0.7% | 31 |
|
|
2018
Q3 | $46.6M | Buy |
456,951
+216,713
| +90% | +$20.9M | 0.69% | 31 |
|
|
2018
Q2 | $19.4M | Buy |
240,238
+158,549
| +194% | +$12.6M | 0.3% | 91 |
|
|
2018
Q1 | $6.02M | Sell |
81,689
-4,113
| -5% | -$308K | 0.14% | 168 |
|
|
2017
Q4 | $6.05M | Buy |
85,802
+8,017
| +10% | +$578K | 0.13% | 172 |
|
|
2017
Q3 | $4.86M | Buy |
+77,785
| New | +$4.61M | 0.11% | 196 |
|
Other funds holding NGVT
VPM
VCM
SCM
Segall Bryant & Hamill's NGVT Position: Q1 2026 in Review
Segall Bryant & Hamill reduced its Ingevity (NGVT) stake by 9% in Q1 2026, selling an estimated $7.47M and leaving 1,109,048 shares worth $79M. The position accounts for 1.13% of the portfolio, ranked #6.
Segall Bryant & Hamill first reported a position in NGVT in Q3 2017 and has held it in 35 quarters since. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Segall Bryant & Hamill held 1,109,048 shares of Ingevity worth $79M as of Q1 2026.
- Segall Bryant & Hamill sold 109,297 Ingevity shares in Q1 2026, an estimated $7.47M.
- Ingevity made up 1.13% of Segall Bryant & Hamill's portfolio in Q1 2026, its #6 holding.
- Segall Bryant & Hamill first reported a position in Ingevity in Q3 2017 and has held it in 35 quarters since.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.